All Videos

Eshani Nandita, Ph.D., Global Biopharma Quant Technical Marketing Lead at Sciex, presented the company’s poster Ultra-Sensitive LC-MRM Analysis for Trastuzumab emtansine Quantification in Rat Plasma at AAPS 2021 PharmSci 360.

Tarun Mutukuri, Ph.D. from Purdue University presented Fluid Air’s poster Electrostatic Spray Drying to Produce Solid Protein Formulations at AAPS 2021 PharmSci 360.

Nanoform’s Eric Peter talks about what Nanoform showcased at AAPS 2021and what makes Nanoform’s particle engineering solutions unique.

Manish Ghimire, Ph.D., Product Development Manager at Colorcon, Inc., presented the company’s poster Impact of Opacifier Type in a Film Coating Formulation on Photostability of Tablet Ingredients at AAPS 2021 PharmSci 360.

Daniel To, Ph.D., Product Development Manager – Film Coatings, at Colorcon, Inc. presented the company’s poster Performance and Stability of an On-Dosage Authentication Technology Using Molecular Tags on the Coated a Model Active at AAPS 2021 PharmSci 360.

Element offers comprehensive solutions for the entire product lifecycle.

Learn how CDMOs have integrated and delivered innovation to advance customers from curiosity to cure.

Dr. Prasad Raje, CEO of LGM Pharma, explores the importance of investing in robust analytical testing services, how pharma companies can leverage contract analytical services to save on costs and reduce development times, and more.

Pharma companies find ways to maintain quality standards, despite pandemic-related restrictions.

Lessons learned from the pandemic can advance future biologic drug development and manufacturing.

The importance of characterizing excipients, supply chain security, and the role of novel excipients are explored.

Representatives of industry organizations discuss crucial business, regulatory, science-based issues facing the industry.

How can artificial intelligence and machine learning be used to gather and process real-time manufacturing data?

Laks Pernenkil, a partner for Deloitte’s life sciences consulting business, discusses various findings from Deloitte’s research into the biopharma industry.